Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Hypertension. 2015 Jul 6;66(3):474–480. doi: 10.1161/HYPERTENSIONAHA.115.05560

Table 2.

The prevalence and awareness of hypertension according to the 7th Joint National Committee and blood pressure classification and treatment rates according to the 7th and 8th Joint National Committee guidelines for the treatment of high blood pressure in 6,088 participants from the 5th visit of the Atherosclerosis Risk in Communities Study, 2011–13.

Total Sample JNC7 Guidelines JNC8P Guidelines Reclassified by JNC8P
Overall (n=6,088)
Prevalence (% of n) 4986 (81.9)
 Awareness (%*) 4035 (80.9)
At Goal BP (% of n) 3822 (62.8) 4,831 (79.4) 1,009 (16.6)
 On BP Medications (%) 2720 (71.2) 3514 (72.7) 794 (78.7)

No Diabetes or CKD (n=2,744) Goal <140/90 Goal <150/90
Prevalence (% of n) 1898 (69.2)
 Awareness (%*) 1467 (77.3)
At Goal BP (% of n) 2,106 (76.8) 2,424 (88.3) 318 (11.6)
 On BP Medications (%) 1260 (59.8) 1465 (60.4) 205 (64.5)

Diabetes or CKD (n=3,344) Goal <130/80 Goal <140/90
Prevalence (% of n) 3088 (92.3)
 Awareness (%*) 2568 (83.2)
At Goal BP (% of n) 1,716 (51.3) 2,407 (72.0) 691 (20.6)
 On BP Medications (%) 1460 (85.1) 2049 (85.1) 589 (85.2)

Abbreviations: JNC – Joint National Committee, CKD – Chronic Kidney Disease, BP – Blood Pressure

*

Percentage of the number with hypertension

Percentage of the number at goal BP

The JNC8P guidelines do not address definitions of hypertension and had not yet been released at the time of data collection so the prevalence and awareness of hypertension according to JNC8P was not analyzed